NDC 80425-0318-01 - Sumatriptan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0318
- Requested NDC
- 80425-0318-01
- Package NDCs from labels
- 80425-0318-1, 80425-0318-2, 80425-0318-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sumatriptan - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0318-1 | Sumatriptan | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 80425-0318-1 | Sumatriptan | 9 in 1 BLISTER PACK | TABLET | 9 | 2 | |
| 80425-0318-2 | Sumatriptan | 9 in 1 BLISTER PACK | TABLET | 9 | 2 | |
| 80425-0318-2 | Sumatriptan | 4 in 1 CARTON | TABLET | 4 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0318 | SUMATRIPTAN TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 4 package rows | 20240829_f8c4bbfb-1586-4610-e053-6394a90a8f09.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0318-1 | EA - Each | 80425-0318 | 38ae2ec2-de34-4dd4-b0b6-d22066b9f76f | 1 | 2023-06-06 |
| 80425-0318-2 | EA - Each | 80425-0318 | 0df75388-d519-4a31-8d32-f1fd155487b4 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sumatriptan | SUMATRIPTAN SUCCINATE | NorthStar Rx LLC | 84bfc4ba-4172-4adb-b963-4e0eb438c07a | 2026-02-13 | Warnings, Adverse reactions | ANDA078327 315223 313160 313161 J8BDZ68989 |
| sumatriptan | SUMATRIPTAN | ONESOURCE SPECIALTY PHARMA LIMITED | 4996682c-cd85-6e39-e063-6294a90a90ae | 2026-01-30 | Warnings, Adverse reactions | J8BDZ68989 |
| sumatriptan | SUMATRIPTAN | ONESOURCE SPECIALTY PHARMA LIMITED | b4240c6e-6b9e-405f-82e6-a3d5bd9e6f29 | 2026-01-30 | Warnings, Adverse reactions | J8BDZ68989 |
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | Alembic Pharmaceuticals Inc. | 0e8b65f7-9d3b-42f2-8d7e-69b143365980 | 2026-01-29 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN | Baxter Healthcare Corporation | d13df081-648c-44c0-9854-5a1bfe23ae89 | 2026-01-28 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Dr. Reddys Laboratories Inc., | 8fef1176-7a38-eca3-22ca-83efe5ca6620 | 2026-01-21 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Sun Pharmaceutical Industries, Inc. | f235152e-dd8d-4679-9d9f-404fe5ff4fba | 2026-01-08 | Warnings, Adverse reactions | J8BDZ68989 |
| IMITREX | SUMATRIPTAN | GlaxoSmithKline LLC | 584abe73-8290-4484-ff8e-5890831c095e | 2025-12-09 | Warnings, Adverse reactions | 315223 313160 313161 J8BDZ68989 |
| IMITREX | SUMATRIPTAN | GlaxoSmithKline LLC | fee7d073-0b99-48f2-7985-0d8cf970894b | 2025-12-09 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan and Naproxen Sodium | SUMATRIPTAN AND NAPROXEN SODIUM | NorthStar RxLLC | 3f2ec27e-0e96-4028-a1fa-114e6d501464 | 2025-11-20 | Boxed warning, Warnings, Adverse reactions | J8BDZ68989 |
| SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | Alembic Pharmaceuticals Limited | 16b7e44d-afa0-4177-80ef-c3ae9a78a4e1 | 2025-11-17 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN | Eugia US LLC | c009976a-4e29-4aeb-9e55-a88766ebb1fb | 2025-11-12 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan and Naproxen Sodium | SUMATRIPTAN AND NAPROXEN SODIUM | Sun Pharmaceutical Industries, Inc. | 96ed12a3-fa76-4afd-bee8-1ab19eb607f3 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Preferred Pharmaceuticals, Inc. | f2e7d756-1e12-462a-a43f-a9d860b11ee8 | 2025-09-25 | Warnings, Adverse reactions | ANDA078327 313161 J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN | Eugia US LLC | 9b1bb8c9-be3a-47c3-b3bc-9c983cde7d23 | 2025-05-29 | Warnings, Adverse reactions | J8BDZ68989 |
| sumatriptan | SUMATRIPTAN | Rising Pharma Holdings, Inc. | 352d2ab3-d2c7-48c8-bcd4-d46ed9bdfa85 | 2025-05-21 | Warnings, Adverse reactions | 315223 313160 313161 J8BDZ68989 |
| Zembrace SymTouch | SUMATRIPTAN SUCCINATE | Tonix Medicines, Inc. | 3eb49807-fa9d-4a0d-9a3c-76de5b23b01b | 2025-02-28 | Warnings, Adverse reactions | J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals, Inc. | 2efd4269-5657-9669-e063-6394a90a583a | 2025-02-25 | Warnings, Adverse reactions | ANDA078327 313161 J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN | NuCare Pharmaceuticals,Inc. | 082d05f6-3850-0fa2-e063-6294a90a0c66 | 2025-02-03 | Warnings, Adverse reactions | 313161 J8BDZ68989 |
| Sumatriptan | SUMATRIPTAN | Direct_Rx | efb7ec4e-0a5d-2aae-e053-2a95a90aebf2 | 2025-01-22 | Warnings, Adverse reactions | 313160 J8BDZ68989 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.